Until recently, the opportunity to have a celebrity attend an event, attach themselves to a name-brand or endorse a certain product or idea was untouchable. The thought of paying a person to promote a product was seen as something only Fortune 500 companies could afford. Social media has changed all that with brands and businesses utilizing celebrity influencers to connect directly with their demographics and increase sales and profits.
The global lyophilisation for pharmaceuticals products and services market will reach $3.09bn in 2014 with revenues showing strong growth to 2024. With increasing numbers of proteins being discovered, the importance of lyophilisation is coming to the fore, for example, as a means of extending the shelf life of pharmaceutical and biopharmaceutical products. SMi invites you to attend the 2nd annual Lyophilisation conference on 7-8 July 2014, London. This event will provide an update on methodologies for lyophilisation and examine how to mitigate risks in production. Join our Lyophilisation forum and gain insight into current successes and challenges faced by pharmaceuticals and biopharmaceuticals during their freeze drying life cycle. Key Speakers Include • Sune Andersen, Principal Scientist, Novo Nordisk • Patrick Garidel, Associate Director, Protein Science, Boehringer Ingelheim • Julie Pagenaud, Sterile Product Manufacturing Manager, Ipsen • Massimo Rastelli, Project Leader BioPharm, GlaxoSmithKline • Andrea Weiland, CEO, Explicat Pharma • Mark Yang, Director of Fill Finish Development, Genzyme • Bertie Daly, Associate Director, Alexion Pharmaceuticals • Jamie Biddlecombe, Formulation Development Scientist, MedImmune • Jason Gray, Consultant, Allembis (ex-Merck) • Professor Dr Thomas de Beer, Laboratory of Process Analytical Technology, Ghent University • Dr Rongjun Chen, Lecturer in Chemical Engineering, Imperial College London Key Topic Insights • First hand case studies from leading experts in lyophilisation • Evaluate practical guidance from both industry and academics • Analyse ways to ensure good product quality at the end of the cycle • Discover the fastest way to delivery within a lyophilisation cycle • How to optimise cycles of products on the market BOOK BY THE 31ST MARCH AND SAVE £300 BOOK BY 30TH APRIL AND SAVE £100 For more information and full programme details please visit: http://www.smi-online.co.uk/2014lyophilisation10.asp Alternatively contact Jonathan Collins for more information +44 (0)207 827 6734 | firstname.lastname@example.org Here is a sample of organisations who have previously attended: Abbvie Deutschland GmbH & Co. KG; Agresearch; Applewood Scientific; Aston University; BioPharma Technology; Boehringer Ingelheim; Dr.Mardon pharmaceutical company; Explicat Pharma GmbH; Fresenius Kabi; GEA Pharma Systems ; general organisation of import and export control; GlaxoSmithKline; Government Pharmaceutical Organization; GRIFOLS VIAJES SA; GSK; GSK Manufacturing S.p.A.; Imperial College; INRA; Intravacc; MedImmune; National Institute For Biological Standards & Control; National Institute Of Public Health And The Environment; NIBSC; Novo Nordisk A / S; Pfizer; Pharmaceutical and Healthcare Sciences Society; Roche Pharmaceuticals; Sanofi-Aventis; Theravectys; UCL; University Of Groningen; University Of Liverpool; University Of Tuebingen; Vrije Universiteit Brussel; Exhibitors This event is for professionals in the fields of: Pharmaceutical and biologicals storage Freeze-drying and lyophilisation Research and development Chemical engineering Sterility Quality assurance and quality control Protein stabilisation Cold chain distribution Freeze-dryer manufacturers Pharmaceutical packaging & labelling Pre-filled syringes Quality by design Up-scaling Vaccine storage Formulation Clinical trial logistics Regulatory compliance